Flecainide to prevent atrial arrhythmia after patent foramen ovale closure Rationale and design of the randomized AFLOAT study
European Heart Journal - Cardiovascular Pharmacotherapy
Enhanced Therapeutic Outcomes with Atezolizumab-Bevacizumab and SIRT Combination compared to SIRT alone in Unresectable HCC: A Promising Approach for Improved Survival
Clinics and Research in Hepatology and Gastroenterology
Cancer-related arterial thromboembolic events
Archives of Cardiovascular Diseases
Cancer-related arterial thromboembolic events